HF
PTIXW

HRT Financial’s Protagenic Therapeutics Warrant PTIXW Stock Holding History

HRT Financial’s Portfolio PTIXW Stock Details PTIXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,119
Closed – – 3366
2025
Q1 		$0 Sell
20,119
-2,150
-10% -$11 ﹤0.01% 3222
2024
Q4 		$0 Buy
+22,269
New +$198 ﹤0.01% 3062

Other funds holding PTIXW

CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

HRT Financial's PTIXW Position: Q2 2025 in Review

HRT Financial sold out of Protagenic Therapeutics Warrant (PTIXW) in Q2 2025, closing a stake of 20,119 shares.

HRT Financial first reported a position in PTIXW in Q4 2024 and held it in 2 quarters. The position peaked at $0 in Q1 2025. 4 funds tracked by Wall St. Rank hold PTIXW as of Q2 2025.

  • HRT Financial reported no remaining Protagenic Therapeutics Warrant position as of Q2 2025 after selling out during the quarter.
  • HRT Financial sold 20,119 Protagenic Therapeutics Warrant shares in Q2 2025.
  • HRT Financial first reported a position in Protagenic Therapeutics Warrant in Q4 2024 and held it in 2 quarters.
  • HRT Financial's Protagenic Therapeutics Warrant position peaked at $0 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Protagenic Therapeutics Warrant as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.